Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jing Niu

Showing results (211-220 of 225) with videos related to

Pageof 23
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|January 15, 2019
Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt CreationLuo Zuo, Yong Lv, Qiuhe Wang, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 2, 2018
Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosisChuangye He, Yong Lv, Zhengyu Wang, et al.
Alimentary Pharmacology & Therapeutics|March 2, 2019
TIPSS for variceal bleeding in patients with idiopathic non-cirrhotic portal hypertension: comparison with patients who have cirrhosisYong Lv, Kai Li, Chuangye He, et al.
Journal of Hepatology|May 17, 2017
Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleedingQiuhe Wang, Yong Lv, Ming Bai, et al.
Investigational New Drugs|July 19, 2018
Hand-foot-skin reaction of grade ≥ 2 within sixty days as the optimal clinical marker best help predict survival in sorafenib therapy for HCCEnxin Wang, Dongdong Xia, Wei Bai, et al.
Gut|October 4, 2017
Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trialYong Lv, Xingshun Qi, Chuangye He, et al.
Hepatology (Baltimore, Md.)|July 25, 2020
Risk Stratification Based on Chronic Liver Failure Consortium Acute Decompensation Score in Patients With Child-Pugh B Cirrhosis and Acute Variceal BleedingYong Lv, Zhengyu Wang, Kai Li, et al.
The Lancet. Gastroenterology & Hepatology|July 8, 2019
Angioplasty with versus without routine stent placement for Budd-Chiari syndrome: a randomised controlled trialQiuhe Wang, Kai Li, Chuangye He, et al.
The Lancet. Gastroenterology & Hepatology|June 3, 2019
Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trialYong Lv, Zhiping Yang, Lei Liu, et al.
Investigational New Drugs|December 14, 2019
Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cellsJie Hu, Enxin Wang, Lei Liu, et al.
Pageof 23

Showing results (211-220 of 225) with videos related to

Sort By:
Pageof 23
Journal of Vascular and Interventional Radiology : JVIR|January 15, 2019
Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt CreationLuo Zuo, Yong Lv, Qiuhe Wang, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 2, 2018
Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosisChuangye He, Yong Lv, Zhengyu Wang, et al.
Alimentary Pharmacology & Therapeutics|March 2, 2019
TIPSS for variceal bleeding in patients with idiopathic non-cirrhotic portal hypertension: comparison with patients who have cirrhosisYong Lv, Kai Li, Chuangye He, et al.
Journal of Hepatology|May 17, 2017
Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleedingQiuhe Wang, Yong Lv, Ming Bai, et al.
Investigational New Drugs|July 19, 2018
Hand-foot-skin reaction of grade ≥ 2 within sixty days as the optimal clinical marker best help predict survival in sorafenib therapy for HCCEnxin Wang, Dongdong Xia, Wei Bai, et al.
Gut|October 4, 2017
Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trialYong Lv, Xingshun Qi, Chuangye He, et al.
Hepatology (Baltimore, Md.)|July 25, 2020
Risk Stratification Based on Chronic Liver Failure Consortium Acute Decompensation Score in Patients With Child-Pugh B Cirrhosis and Acute Variceal BleedingYong Lv, Zhengyu Wang, Kai Li, et al.
The Lancet. Gastroenterology & Hepatology|July 8, 2019
Angioplasty with versus without routine stent placement for Budd-Chiari syndrome: a randomised controlled trialQiuhe Wang, Kai Li, Chuangye He, et al.
The Lancet. Gastroenterology & Hepatology|June 3, 2019
Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trialYong Lv, Zhiping Yang, Lei Liu, et al.
Investigational New Drugs|December 14, 2019
Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cellsJie Hu, Enxin Wang, Lei Liu, et al.
Pageof 23